How big is Outlook Therapeutics, Inc.?

Jun 22 2025 06:06 PM IST
share
Share Via
As of Jun 18, Outlook Therapeutics, Inc. has a market capitalization of 72.42 million and reported net sales of 0.00 million with a net profit of 21.12 million over the latest four quarters. As of Sep 24, the company has shareholder's funds of -73.08 million and total assets of 28.82 million.
As of Jun 18, Outlook Therapeutics, Inc. has a market capitalization of 72.42 million, categorizing it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 0.00 million, while the sum of net profit for the same period is 21.12 million.

As of Sep 24, the reporting period for the balance sheet shows shareholder's funds of -73.08 million and total assets of 28.82 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Outlook Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:27 PM IST
share
Share Via
Is Outlook Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:06 AM IST
share
Share Via
What does Outlook Therapeutics, Inc. do?
Jun 22 2025 06:50 PM IST
share
Share Via